QHA

X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device

Product code
QHA
Device name
X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
Device class
Class 2
21 CFR
21 CFR 892.1600
Medical specialty
Radiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
3
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
7 (all years; only the last 3 years are listed here)

FDA classification definition

X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology applications. X-ray angiographic imaging based coronary vascular simulation software device cannot be used alone for clinical decision making and clinical management, and is a tool intended to generate results for use and review by a qualified clinician.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2025-10-17.

NumberDecision dateApplicantDevice nameSummary
K2513552025-10-17Spectrawave, Inc.X1-FFRPDF
K2437692025-04-04Qfr Solutions BVQFR (3.0)PDF
K2321472024-04-09Pie Medical Imaging BVCAAS WorkstationPDF

3 summaries are archived here for direct download.

Official FDA classification page: QHA
Classification and pathway per current FDA publications. Data from openFDA (CC0).